검색 상세

The Economic Burden of Breast Cancer in Korea from 2007-2010

The Economic Burden of Breast Cancer in Korea from 2007-2010

초록/요약

Purpose This study estimates the socioeconomic cost and burden for breast cancer patients in Koreabetween 2007 and 2010. Materials and MethodsThis study used a prevalence-based approach to estimate the cost of breast cancer. Breastcancer patients were defined as those who were hospitalized or have visited an outpatientclinic during the period from 2007 to 2010. The socioeconomic costs of breast cancer weresubdivided into two costs: direct and indirect. ResultsFrom 2007 to 2010, the prevalence of treated breast cancer increased from 7.9% to 20.4%. The total socioeconomic costs incurred by breast cancer increased by approximately 40.7%from US $668.49 million in 2007 to US $940.75 million in 2010. The direct medical carecosts for 2010 were 1.4 times greater (US $399.22 million) than for 2007 (US $278.71million). The direct non-medical costs rose from US $50.69 million in 2007 to US $75.83million in 2010, a 49.6% increase. Regarding the economic burden of breast cancer, thetotal indirect costs were US $339.09 million in 2007 and increased by 37.3% to US$465.70 million in 2010. In the sensitivity analysis, with the annual discount rate for eachyear ranging from 0%-5%, the costs increased 1.1-1.2 times. ConclusionDue to the growing incidence of breast cancer, the annual prevalence and related costs areincreasing. We must strive to reduce the socioeconomic burden of breast cancer throughpreventive measures and early screening.

more